Molecular imaging in the aid of drug delivery technology
- Authors
- Cho, Yong Woo; Kim, Kwangmyeung; Park, Kinam; Kwon, Ick Chan
- Issue Date
- 9월-2014
- Publisher
- POLYMER SOC KOREA
- Keywords
- molecular imaging; drug delivery system; theragnostics; tumor; nanomedicine
- Citation
- MACROMOLECULAR RESEARCH, v.22, no.9, pp.926 - 931
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- MACROMOLECULAR RESEARCH
- Volume
- 22
- Number
- 9
- Start Page
- 926
- End Page
- 931
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/97616
- DOI
- 10.1007/s13233-014-2127-5
- ISSN
- 1598-5032
- Abstract
- Molecular imaging aims to visualize biological processes in a living system at a molecular or cellular level while drug delivery systems (DDS) aim to deliver drugs to specific targets of tissues or organs at a controlled rate. Molecular imaging and DDS, seemingly two different subjects, however, are not completely separate. They share overlapped conceptual and technological spectra. To visualize molecular events in body molecular imaging requires delivery of imaging probes to specific targets, which has been the main technology developed in DDS for decades. Simply replacing drugs in targeted therapeutic DDS with imaging probes turns the whole system to targeted imaging system for diagnosis of diseases. Integrating imaging probes into therapeutic DDS is a starting point for theragnotics, therapy, and diagnosis performed simultaneously with one agent. Key DDS technologies applied to molecular imaging have played an important role in advances of molecular imaging. We here briefly discuss molecular imaging in the aid of drug delivery technology, with an emphasis on theragnotics of tumors.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > KU-KIST Graduate School of Converging Science and Technology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.